This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1998 Mar;31(2):72.

doi: 10.1055/s-2007-979303.

Ultrarapid metabolism of clomipramine in a therapy-resistant depressive patient, as confirmed by CYP2 D6 genotyping

P Baumann, F Broly, M Kosel, C B Eap

PMID: 9562213
DOI: 10.1055/s-2007-979303

Case Reports

Ultrarapid metabolism of clomipramine in a therapy-resistant depressive patient, as confirmed by CYP2 D6 genotyping

P Baumann et al. Pharmacopsychiatry. 1998 Mar.

. 1998 Mar;31(2):72.

doi: 10.1055/s-2007-979303.

Authors

P Baumann, F Broly, M Kosel, C B Eap

PMID: 9562213
DOI: 10.1055/s-2007-979303

No abstract available

PubMed Disclaimer

Similar articles

Pharmacokinetic fluvoxamine-clomipramine interaction with favorable therapeutic consequences in therapy-resistant depressive patient.
Conus P, Bondolfi G, Eap CB, Macciardi F, Baumann P. Conus P, et al. Pharmacopsychiatry. 1996 May;29(3):108-10. doi: 10.1055/s-2007-979554. Pharmacopsychiatry. 1996. PMID: 8738315
Clomipramine, fluoxetine and CYP2D6 metabolic capacity in depressed patients.
Vandel P, Haffen E, Nezelof S, Broly F, Kantelip JP, Sechter D. Vandel P, et al. Hum Psychopharmacol. 2004 Jul;19(5):293-8. doi: 10.1002/hup.598. Hum Psychopharmacol. 2004. PMID: 15252821 Clinical Trial.
Citalopram: an interaction study with clomipramine in a patient heterozygous for CYP2D6 genotype.
Haffen E, Vandel P, Broly F, Vandel S, Sechter D, Bizouard P, Bechtel PR. Haffen E, et al. Pharmacopsychiatry. 1999 Nov;32(6):232-4. doi: 10.1055/s-1999-7960. Pharmacopsychiatry. 1999. PMID: 10599932
Serum clomipramine and desmethylclomipramine levels in a CYP2C19 and CYP2D6 intermediate metabolizer.
Brown JT, Schneiderhan M, Eum S, Bishop JR. Brown JT, et al. Pharmacogenomics. 2017 May;18(7):601-605. doi: 10.2217/pgs-2017-0015. Epub 2017 May 4. Pharmacogenomics. 2017. PMID: 28470111 Review.
[Clinical pharmacokinetics of tricyclic antidepressants. Part I. Pharmacokinetic properties].
Szymura-Oleksiak J, Wasieczko A, Wyska E, Zieba A. Szymura-Oleksiak J, et al. Psychiatr Pol. 1993 Nov-Dec;27(6):683-91. Psychiatr Pol. 1993. PMID: 8134502 Review. Polish.

See all similar articles

Cited by

Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism.
Rochat B. Rochat B. Clin Pharmacokinet. 2005;44(4):349-66. doi: 10.2165/00003088-200544040-00002. Clin Pharmacokinet. 2005. PMID: 15828850 Review.
Number of risk genotypes is a risk factor for major depressive disorder: a case control study.
Garriock HA, Delgado P, Kling MA, Carpenter LL, Burke M, Burke WJ, Schwartz T, Marangell LB, Husain M, Erickson RP, Moreno FA. Garriock HA, et al. Behav Brain Funct. 2006 Jul 5;2:24. doi: 10.1186/1744-9081-2-24. Behav Brain Funct. 2006. PMID: 16822313 Free PMC article.
Increased incidence of CYP2D6 gene duplication in patients with persistent mood disorders: ultrarapid metabolism of antidepressants as a cause of nonresponse. A pilot study.
Kawanishi C, Lundgren S, Agren H, Bertilsson L. Kawanishi C, et al. Eur J Clin Pharmacol. 2004 Jan;59(11):803-7. doi: 10.1007/s00228-003-0701-4. Epub 2003 Dec 2. Eur J Clin Pharmacol. 2004. PMID: 14652703
Treatment resistance in psychiatry: state of the art and new directions.
Howes OD, Thase ME, Pillinger T. Howes OD, et al. Mol Psychiatry. 2022 Jan;27(1):58-72. doi: 10.1038/s41380-021-01200-3. Epub 2021 Jul 13. Mol Psychiatry. 2022. PMID: 34257409 Free PMC article. Review.
Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.
Eap CB, Buclin T, Baumann P. Eap CB, et al. Clin Pharmacokinet. 2002;41(14):1153-93. doi: 10.2165/00003088-200241140-00003. Clin Pharmacokinet. 2002. PMID: 12405865 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Georg Thieme Verlag Stuttgart, New York
Molecular Biology Databases
- Pharmacogenomics Knowledge Base